S755 Early Symptom Control With Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis in the LUCENT-1 Induction Trial. (October 2022) - Danese, Silvio; Dignass, Axel; Matsuoka, Katsuyoshi; Ferrante, Marc; Redondo, Isabel; Gibble, Theresa Hunter; Moses, Richard; Morris, Nathan; Li, Xingyuan; Milch, Catherine; Abreu, Maria T.